1. Home
  2. AIMD vs DLPN Comparison

AIMD vs DLPN Comparison

Compare AIMD & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • DLPN
  • Stock Information
  • Founded
  • AIMD 1984
  • DLPN 1996
  • Country
  • AIMD United States
  • DLPN United States
  • Employees
  • AIMD N/A
  • DLPN N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • DLPN Other Consumer Services
  • Sector
  • AIMD Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • AIMD 11.9M
  • DLPN 12.3M
  • IPO Year
  • AIMD N/A
  • DLPN N/A
  • Fundamental
  • Price
  • AIMD $2.86
  • DLPN $1.22
  • Analyst Decision
  • AIMD
  • DLPN Strong Buy
  • Analyst Count
  • AIMD 0
  • DLPN 1
  • Target Price
  • AIMD N/A
  • DLPN $5.00
  • AVG Volume (30 Days)
  • AIMD 75.3K
  • DLPN 27.1K
  • Earning Date
  • AIMD 08-04-2025
  • DLPN 08-13-2025
  • Dividend Yield
  • AIMD N/A
  • DLPN N/A
  • EPS Growth
  • AIMD N/A
  • DLPN N/A
  • EPS
  • AIMD N/A
  • DLPN N/A
  • Revenue
  • AIMD $106,207.00
  • DLPN $48,618,803.00
  • Revenue This Year
  • AIMD N/A
  • DLPN $6.57
  • Revenue Next Year
  • AIMD N/A
  • DLPN $18.10
  • P/E Ratio
  • AIMD N/A
  • DLPN N/A
  • Revenue Growth
  • AIMD 13.38
  • DLPN 0.31
  • 52 Week Low
  • AIMD $2.00
  • DLPN $0.75
  • 52 Week High
  • AIMD $5.00
  • DLPN $2.00
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 48.86
  • DLPN 52.21
  • Support Level
  • AIMD $3.07
  • DLPN $1.20
  • Resistance Level
  • AIMD $3.34
  • DLPN $1.29
  • Average True Range (ATR)
  • AIMD 0.24
  • DLPN 0.08
  • MACD
  • AIMD 0.01
  • DLPN -0.00
  • Stochastic Oscillator
  • AIMD 54.84
  • DLPN 40.63

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: